erythromycin has been researched along with ru 66647 in 131 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (13.74) | 18.2507 |
2000's | 92 (70.23) | 29.6817 |
2010's | 17 (12.98) | 24.3611 |
2020's | 4 (3.05) | 2.80 |
Authors | Studies |
---|---|
Appelbaum, PC; Ednie, LM; Jacobs, MR | 1 |
Appelbaum, PC; Jacobs, MR; Pankuch, GA; Visalli, MA | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 3 |
Bryskier, A; Hoppe, JE | 1 |
Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV | 1 |
Bryskier, A; Lütticken, R; Reinert, RR | 1 |
Hammerschlag, MR; Roblin, PM | 1 |
Hamilton-Miller, JM; Shah, S | 1 |
Eliopoulos, GM; Moellering, RC; Schülin, T; Wennersten, CB | 1 |
Baquero, F; Portillo, A; Ruiz, F; Saenz, Y; Tenorio, C; Torres, C; Zarazaga, M | 1 |
Agouridas, C; Denis, A | 1 |
Douthwaite, S; Hansen, LH; Mauvais, P | 2 |
Mankin, AS; Mauvais, P; Shah, S; Xiong, L | 1 |
Appelbaum, PC; Credito, KL; Ednie, LM; Jacobs, MR | 1 |
Collart-Dutilleul, V; Diu-Hercend, A; Maridonneau-Parini, I; Miossec-Bartoli, C; N'Diaye, EN; Peyron, P; Pilatre, L | 1 |
Agouridas, C; Auger, JM; Benedetti, Y; Bonnefoy, A; Bretin, F; Chantot, JF; D'Ambrières, SG; Denis, A; Dussarat, A; Fromentin, C; Lachaud, S; Laurin, P; Le Martret, O; Loyau, V; Pejac, JM; Perron, S; Tessot, N | 1 |
Baquero, F; Del Campo, R; Portillo, A; Ruiz-Larrea, F; Sáenz, Y; Tenorio, C; Torres, C; Zarazaga, M | 1 |
Appelbaum, PC; Davies, TA; Jacobs, MR; Kelly, LM | 1 |
Borlace, G; Munckhof, WJ; Turnidge, JD | 1 |
Baltch, AL; Franke, MA; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
Bemer-Melchior, P; Bryskier, A; Drugeon, HB; Juvin, ME; Schito, GC; Tassin, S | 1 |
Ishii, Y; Miyazaki, S; Okamoto, H; Tateda, K; Yamaguchi, K | 2 |
Murray, BE; Singh, KV; Zscheck, KK | 1 |
Giovanetti, E; Marchetti, F; Montanari, MP; Varaldo, PE | 1 |
Andrews, JM; Ashby, JP; Walker, RM; Weller, TM; Wise, R | 1 |
Charles, PE; Chavanet, P; Desbiolles, N; Lequeu, C; Martin, L; Mateo-Ponce, V; Piroth, L; Portier, H | 1 |
Muller-Serieys, C | 1 |
Huovinen, P; Jalava, J; Kataja, J; Seppälä, H | 1 |
Bryskier, A; Calvo, R; Esteban, J; Fernández-Roblas, R; Soriano, F | 1 |
Bryskier, A | 1 |
Bonnefoy, A; Delachaume, C; Girard, AM; Guitton, M; Le Priol, P | 1 |
Biedenbach, DJ; Jones, RN; Rospide, MF | 1 |
Hoban, DJ; Nichol, K; Wierzbowski, AK; Zhanel, GG | 1 |
Brandt, CM; Bryskier, A; Holland, R; Honscha, M; Hövener, B; Lütticken, R; Reinert, RR; Truong, ND | 1 |
Henwood, CJ; Johnson, AP; Tysall, L; Warner, M | 1 |
Almaraz, F; Baquero, F; Cantón, R; Galán, JC; Loza, E; Morosini, MI; Negri, MC | 1 |
Cartwright, FD; Kenny, GE | 1 |
Su, WG; Wu, YJ | 1 |
Appelbaum, PC; Bryskier, A; Davies, TA; Ednie, LM; Jacobs, MR; Nagai, K; Palavecino, E | 1 |
Benjamin, WH; Crain, MC; Edwards, KM; Gray, BM; Johnson, CN; Waites, KB | 1 |
Andrasevic, AT; Appelbaum, PC; Davies, TA; Drukalska, L; Hoellman, DB; Hryniewicz, W; Hupkova, H; Jacobs, MR; Kelly, LM; Kolman, J; Miciuleviciene, J; Nagai, K; Pana, M; Setchanova, L; Thege, MK; Trupl, J; Urbaskova, P | 1 |
Almer, LS; Beyer, JM; Cao, Z; Doktor, SZ; Flamm, RK; Ramer, NC; Shortridge, VD; Zhong, P | 1 |
Astfalk, N; Jagusch, H; Petridou, J; Scheuring, S; Schmitz, FJ; Schwarz, S | 1 |
Fluit, AC; Milatovic, D; Schmitz, FJ; Schwarz, S; Verhoef, J | 1 |
Champney, WS; Pelt, J | 1 |
Cortes, L; Guilbault, C; Low, DE; Restieri, C; Weiss, K | 1 |
Ma, Z; Nilius, AM | 1 |
Astfalk, N; Köhrer, K; Petridou, J; Scheuring, S; Schmitz, FJ; Schwarz, S | 1 |
Chuah, SK; Gollapudi, S; Iskandar, L; Thadepalli, H | 1 |
Champney, WS | 1 |
Shortridge, V; Zhong, P | 1 |
Champney, WS; Tober, CL | 1 |
Agreda, MC; Betriu, C; Culebras, E; Gómez, M; Picazo, JJ; Rodríguez-Avial, I; Sánchez, BA | 1 |
Quinn, J; Ruoff, GE; Ziter, PS | 1 |
Hoban, DJ; Low, DE; Nichol, KA; Palatnick, L; Zhanel, GG | 1 |
Almaraz, F; Baquero, F; Cantón, R; del Campo, R; Loza, E; Morosini, MI | 1 |
Chang, FY; Chuang, YC; Hsueh, PR; Huang, WK; Ko, WC; Lau, YJ; Lee, CM; Leu, HS; Liu, CY; Liu, YC; Lu, JJ; Luh, KT; Shyr, JM; Teng, LJ; Wan, JH; Wu, JJ; Wu, TL; Yan, JJ; Yang, D; Yang, YC | 2 |
Bidet, P; Bingen, E; Brahimi, N; Deforche, D; Doit, C; Geslin, P; Loukil, C | 1 |
Ashi-Sulaiman, A; de Azavedo, JS; Duncan, CL; Katz, KC; Low, DE; McCann, J; McGeer, AJ; Pong-Porter, S; Rzayev, Y; Sarabia, A; Willey, BM | 1 |
Berisio, R; Fucini, P; Hansen, HA; Harms, J; Schluenzen, F; Yonath, A; Zarivach, R | 1 |
Besier, S; Brade, V; Giesser, I; Hunfeld, KP; Schäfer, V; Wichelhaus, TA | 1 |
Amyes, S; Walsh, F; Willcock, J | 1 |
Chronopoulou, G; Foustoukou, M; Ioannidou, S; Kanavaki, S; Kanelopoulou, M; Pangalis, A; Papafraggas, E; Petropoulou, N; Salem, Z; Tassios, PT; Trikka-Graphakos, E; Vatopoulos, AC; Zachariadou, L | 1 |
Appelbaum, PC; Bajaksouzian, S; Jacobs, MR | 1 |
Aktaş, Z; Berkiten, R; Gönüllü, N; Gürol, D; Küçükbasmaci, O | 1 |
Hisanaga, T; Hoban, DJ; Nichol, K; Wierzbowski, A; Zhanel, GG | 1 |
Acker, G; Brade, V; Hunfeld, KP; Kraiczy, P; Rödel, R; Wichelhaus, TA | 1 |
Crawford, SA; Jorgensen, JH; McElmeel, ML; Whitney, CG | 1 |
Bidet, P; Bingen, E; Brahimi, N; Deforche, D; Doit, C | 1 |
Andrews, JM; Brenwald, NP; Fraise, AP; Harnett, SJ; Jevons, G; Wise, R | 1 |
Canales, M; Capilla, S; Cerdá Zolezzi, P; Durán, E; Gómez-Lus, R; Goñi, P; Millán, L; Rubio Calvo, MC | 1 |
Bagel, S; Brauers, J; Henrichfreise, B; Kresken, M; Wiedemann, B | 1 |
Bryskier, A; Chevalier, J; Chollet, R; Pagès, JM | 1 |
Champney, WS; Mentens, N; Zurawick, K | 1 |
Andersen, NM; Douthwaite, S; Jakobsen, L; Novotny, GW; Poehlsgaard, J | 1 |
Appelbaum, PC; Bozdogan, B; Clark, CL; Credito, KL; Ednie, LM; Jacobs, MR; Kelly, LM; Kosowska, K; Lin, G; Matic, V; McGhee, P; Pankuch, GA; Smith, K | 1 |
Appelbaum, PC; Clark, C; Credito, K; Dewasse, B; Hoellman, D; Jacobs, MR; Kosowska, K; Lin, G; McGhee, P; Pankuch, GA | 1 |
Almela, M; Marco, F; Mensa, J; Ortega, M; Puig, J; Soriano, A | 1 |
Korkhin, Y; Mankin, AS; Xiong, L | 1 |
Abbanat, D; Bush, K; Foleno, B; Li, Y; Macielag, M; Montenegro, D; Webb, G; Wira, E | 1 |
Canu, A; Devenyns, I; Lagrou, K; Leclercq, R; Massonet, C; Meekers, E; Syrogiannopoulos, G; Van Eldere, J; Verhaegen, J | 1 |
Blaha, G; Moore, PB; Steitz, TA; Tu, D | 1 |
Bosnar, M; Eraković, V; Kelnerić, Z; Munić, V; Parnham, MJ | 1 |
Andreu, A; Gonzalez, JJ | 1 |
Crawford, SA; Davis, KA; Fiebelkorn, KR; Jorgensen, JH | 1 |
Dunbar, L; Fogarty, C; Kohno, S; Nusrat, R; Rangaraju, M; van Rensburg, DJ | 1 |
Al-Lahham, A; Reinert, RR; van der Linden, M | 1 |
Bolla, JM; Mamelli, L; Mégraud, F; Pagès, JM; Prouzet-Mauléon, V | 1 |
Choi, SH; Choo, EJ; Jeong, JY; Kim, NJ; Kim, YS; Kwak, YG; Lee, MS; Park, SJ; Ryu, J; Woo, JH | 1 |
De Salvo, MC; Fogarty, C; Nusrat, R; Rangaraju, M; van Rensburg, D | 1 |
Boyd, D; Hoban, DJ; Mulvey, M; Wierzbowski, AK; Zhanel, GG | 1 |
Abbanat, D; Bush, K; Foleno, BD; Henninger, TC; Macielag, MJ; Marinelli, BA; Zhu, B | 1 |
Al-Lahham, A; Grivea, IN; Katopodis, GD; Reinert, RR; Syrogiannopoulos, GA | 1 |
D'Costa, VM; Hughes, DW; McGrann, KM; Wright, GD | 1 |
Eerola, E; Hänninen, ML; Katila, ML; Kaukoranta, SS; Koskela, M; Pajarre, S; Rautelin, H; Schönberg-Norio, D; Uksila, J | 1 |
Crimin, K; Engtrakul, J; Fermini, B; Fossa, AA; O'Donnell, J; Wisialowski, T | 1 |
Barker, L; Burger, MT; Chu, DT; Desai, MC; Hiebert, C; Kidney, J; Langhorne, M; Plattner, JJ; Seid, M; Shawar, R | 1 |
Chesneau, O; Courvalin, P; Tsvetkova, K | 1 |
Cornaglia, G; Koncan, R; Mazzariol, A; Vitali, LA | 1 |
Choi, EC; Kim, H; Kwon, AR; Shim, MJ; Yoon, EJ; Yoon, JM | 1 |
Ackermann, A; Bachmakov, I; Brune, K; Dörje, F; Dormann, H; Eberl, S; Fromm, MF; Gassmann, KG; Hahn, EG; König, J; Mürdter, TE; Neubert, A; Reisig, M; Renner, B; Zierhut, S | 1 |
Janata, J; Novotná, G; Spízek, J | 1 |
Ando, S; Inoue, M; Kishimoto, T; Ogawa, M; Sato, K; Takemura, H; Yamazaki, T | 1 |
Allizond, V; Andreotti, S; Banche, G; Barbui, A; Carlone, NA; Cuffini, AM; Gaido, E; Li Vigni, N; Malabaila, A; Mandras, N; Roana, J; Savoia, D; Scalas, D; Tullio, V | 1 |
Chen, XZ; Jin, ZP; Lei, PS; Li, Y; Liu, J; Liu, L; Wang, GQ; Xu, P | 1 |
Castanheira, M; Jones, RN; Woosley, LN | 1 |
Tang, D; Ying, L | 1 |
Abdalla, S; El-Domany, R; El-Mahdy, TS; Mohamed, MS; Ross, JI; Snelling, AM | 1 |
Giguère, S; Javsicas, LH; Womble, AY | 1 |
Cate, JH; Dunkle, JA; Mankin, AS; Xiong, L | 1 |
Blaha, G; Bulkley, D; Innis, CA; Steitz, TA | 1 |
Akbergenov, R; Akshay, S; Bertea, M; Böttger, EC; Hobbie, SN; Oettinghaus, B; Shcherbakov, D | 1 |
Bencetić Mihaljević, V; Letfus, V; Milić, A; Padovan, J; Ralić, J | 1 |
Dinos, GP; Kalpaxis, DL; Krokidis, MG; Márquez, V; Wilson, DN | 1 |
Hofmann, T; Scheuch, G; Siekmeier, R | 1 |
Gumbart, JC; Pavlova, A | 1 |
Gupta, P; Gupta, V; Klepacki, D; Liu, B; Mankin, AS; Schulten, K; Vázquez-Laslop, N | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
Gumbart, JC; Oyelere, AK; Parks, JM; Pavlova, A | 1 |
Baldassarri, L; Di Bonaventura, G; Gherardi, G; Monaco, M; Pantosti, A; Pimentel de Araujo, F; Pompilio, A | 1 |
Feng, Y; Guo, Q; Shao, B | 1 |
Min, YH | 1 |
Pejčić, AV | 1 |
Abdelshahid, M; Arenz, S; Beckert, B; Bock, LV; Graf, M; Grubmüller, H; Innis, CA; Leroy, EC; Mankin, AS; Seip, B; Sothiselvam, S; Svetlov, MS; Vázquez-Laslop, N; Wilson, DN | 1 |
Chen, Z; Deng, X; Fang, Y; Hu, Y; Li, D; Ouyang, L; Xu, H; Yu, Z; Zhang, H; Zheng, J | 1 |
9 review(s) available for erythromycin and ru 66647
Article | Year |
---|---|
[Ketolides and oxazolidinones. Mechanisms of action and antibacterial spectrum].
Topics: Acetamides; Anti-Bacterial Agents; Erythromycin; Gram-Positive Bacterial Infections; Humans; Ketolides; Linezolid; Macrolides; Microbial Sensitivity Tests; Oxazolidinones; Respiratory Tract Infections; Streptococcus; Structure-Activity Relationship | 2000 |
Ketolides-telithromycin, an example of a new class of antibacterial agents.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Gram-Positive Cocci; Humans; Ketolides; Macrolides | 2000 |
Recent developments on ketolides and macrolides.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Drug Design; Drug Evaluation, Preclinical; Erythromycin; Ketolides; Ketones; Macrolides; Structure-Activity Relationship | 2001 |
Bacterial ribosomal subunit synthesis: a novel antibiotic target.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Erythromycin; Ketolides; Macrolides; Protein Biosynthesis; Protein Synthesis Inhibitors; Ribosomal Proteins; Ribosomes | 2001 |
The emerging new generation of antibiotic: ketolides.
Topics: Anti-Bacterial Agents; Binding Sites; Drug Design; Erythromycin; Ketolides; Macrolides; Ribosomes; RNA, Ribosomal, 23S | 2001 |
Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Ketolides; Macrolides; Respiratory Tract Infections; Streptococcus pneumoniae | 2003 |
Recent advances in the medicinal chemistry of novel erythromycin-derivatized antibiotics.
Topics: Anti-Bacterial Agents; Azithromycin; Chemistry, Pharmaceutical; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides | 2010 |
Inhalation of macrolides: a novel approach to treatment of pulmonary infections.
Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Cystic Fibrosis; Erythromycin; Humans; Ketolides; Lung; Macrolides; Pulmonary Disease, Chronic Obstructive; Rats | 2015 |
Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Humans; Ketolides; Macrolides; Roxithromycin; Stevens-Johnson Syndrome | 2021 |
4 trial(s) available for erythromycin and ru 66647
Article | Year |
---|---|
Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Ketolides; Macrolides; Male; Middle Aged; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 2003 |
Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Erythromycin; Female; Humans; Ketolides; Male; Middle Aged; Penicillin Resistance; Pneumonia, Pneumococcal; Treatment Outcome | 2005 |
Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniae.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Ketolides; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Treatment Outcome | 2005 |
Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies.
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bilirubin; Biological Transport; Caco-2 Cells; Creatinine; Digitoxin; Digoxin; Drug Interactions; Erythromycin; Female; Heart Diseases; Humans; Inpatients; Inulin; Ketolides; Macrolides; Male; Pharmacoepidemiology | 2007 |
118 other study(ies) available for erythromycin and ru 66647
Article | Year |
---|---|
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004).
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; Carbon Dioxide; Clarithromycin; Erythromycin; Hydrogen-Ion Concentration; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin | 1997 |
Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.
Topics: Anti-Bacterial Agents; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae | 1998 |
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).
Topics: Anti-Bacterial Agents; Clindamycin; Erythromycin; Humans; Ketolides; Macrolides; Penicillin Resistance; Phenotype; Pneumococcal Infections; Streptococcus pneumoniae; Virginiamycin | 1998 |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella; Bordetella pertussis; Clarithromycin; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Rifabutin; Rifampin; Roxithromycin | 1998 |
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated f
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bites, Human; Clarithromycin; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin; Skin Diseases, Bacterial; Soft Tissue Infections; Wounds and Injuries | 1998 |
In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple; Erythromycin; Germany; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae | 1998 |
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Chlamydophila pneumoniae; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin | 1998 |
Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Gram-Positive Cocci; Ketolides; Macrolides; Microbial Sensitivity Tests | 1998 |
In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Gram-Positive Bacteria; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests | 1998 |
In vitro activity of the new ketolide HMR3647 in comparison with those of macrolides and pristinamycins against Enterococcus spp.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Phenotype; Virginiamycin | 1998 |
Synthesis of 6-O-methyl-azithromycin and its ketolide analogue via Beckmann rearrangement of 9(E)-6-O-methyl-erythromycin oxime.
Topics: Anti-Bacterial Agents; Azithromycin; Erythromycin; Escherichia coli; Haemophilus influenzae; Ketolides; Macrolides; Microbial Sensitivity Tests; Models, Molecular; Staphylococcus aureus; Streptococcus; Structure-Activity Relationship | 1998 |
The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA.
Topics: Anti-Bacterial Agents; Base Sequence; Binding Sites; Cell Division; Erythromycin; Escherichia coli; Ketolides; Macrolides; Molecular Sequence Data; Nucleic Acid Conformation; RNA, Ribosomal, 23S | 1999 |
A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre.
Topics: Anti-Bacterial Agents; Base Sequence; Binding Sites; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Ketolides; Macrolides; Molecular Sequence Data; Mutation; Nucleic Acid Conformation; Peptidyl Transferases; Ribosomes; RNA, Ribosomal, 23S | 1999 |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; beta-Lactamases; Clarithromycin; Clindamycin; Drug Therapy, Combination; Erythromycin; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Ketolides; Macrolides; Metronidazole; Microbial Sensitivity Tests; Roxithromycin; Virginiamycin | 1999 |
The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonuclear cells.
Topics: Anti-Bacterial Agents; Cell Line; Centrifugation; Cytoplasmic Granules; Erythromycin; Humans; Ketolides; Leukocytes, Mononuclear; Macrolides; Neutrophils; Subcellular Fractions | 1999 |
Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Ketolides; Macrolides; Mice; Microbial Sensitivity Tests; Molecular Structure | 1999 |
In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Erythromycin; Ketolides; Lactobacillus; Leuconostoc; Macrolides; Microbial Sensitivity Tests; Pediococcus | 1999 |
Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae | 2000 |
Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
Topics: Anti-Bacterial Agents; Base Sequence; Binding Sites; Clarithromycin; Drug Interactions; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Ketolides; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Protein Synthesis Inhibitors; Ribosomes; RNA, Ribosomal, 23S | 2000 |
Postantibiotic suppression of growth of erythromycin A-susceptible and -resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Ketolides; Macrolides; Staphylococcus; Streptococcus | 2000 |
Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Ketolides; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Macrolides; Monocytes; Ofloxacin | 2000 |
In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon Dioxide; Culture Media; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Polymerase Chain Reaction; Streptococcus pyogenes | 2000 |
Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Gram-Positive Bacteria; Humans; Japan; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus | 2000 |
Efficacy of telithromycin (HMR 3647) against enterococci in a mouse peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterococcus; Erythromycin; Ketolides; Macrolides; Mice; Microbial Sensitivity Tests; Peritonitis | 2000 |
In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Streptococcus pneumoniae; Streptococcus pyogenes | 2000 |
The in vitro activity of ABT773, a new ketolide antimicrobial agent.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Ketolides; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests | 2000 |
HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Humans; Ketolides; Macrolides; Male; Penicillins; Pneumonia, Pneumococcal; Rabbits; Streptococcus pneumoniae; Treatment Outcome | 2001 |
In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Phenotype; Streptococcus | 2001 |
The bactericidal activities of HMR 3004, HMR 3647 and erythromycin against gram-positive bacilli and development of resistance.
Topics: Animals; Anti-Bacterial Agents; Corynebacterium; Drug Resistance, Microbial; Erythromycin; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Mutation; Serum Bactericidal Test | 1999 |
In vivo efficacy of the new ketolide telithromycin (HMR 3647) in murine infection models.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Biological Availability; Erythromycin; Half-Life; Injections, Intravenous; Ketolides; Macrolides; Male; Mice; Microbial Sensitivity Tests; Virginiamycin | 2001 |
Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gram-Positive Cocci; Haemophilus influenzae; Humans; Ketolides; Macrolides; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2001 |
Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Canada; Drug Resistance, Microbial; Erythromycin; Gene Frequency; Humans; Ketolides; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2001 |
Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany.
Topics: Anti-Bacterial Agents; Drug Resistance; Erythromycin; Genotype; Germany; Ketolides; Macrolides; Microbial Sensitivity Tests; Pharynx; Phenotype; Polymorphism, Restriction Fragment Length; Regulon; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Streptococcal Infections; Streptococcus pyogenes; Streptogramins; Virginiamycin | 2001 |
Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clindamycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Ketolides; Macrolides; Membrane Proteins; Methyltransferases; Streptococcus pneumoniae | 2001 |
In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Spain; Streptococcus pneumoniae; Virginiamycin | 2001 |
Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities
Topics: 4-Quinolones; Acetamides; Aminoglycosides; Anti-Bacterial Agents; Aza Compounds; Erythromycin; Fluoroquinolones; Gatifloxacin; Humans; Hydrogen-Ion Concentration; Ketolides; Linezolid; Macrolides; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycoplasma hominis; Mycoplasma pneumoniae; Oxazolidinones; Quinolines; Tetracyclines; Tigecycline; Ureaplasma urealyticum; Virginiamycin | 2001 |
Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Resistance, Microbial; Erythromycin; Gram-Positive Cocci; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Probability; Sensitivity and Specificity | 2001 |
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae an
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Drug Resistance; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Streptococcus pneumoniae; Streptococcus pyogenes | 2001 |
In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Half-Life; Ketolides; Macrolides; Male; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2001 |
In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Child; Dose-Response Relationship, Drug; Drug Resistance; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2001 |
Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory Standards.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Clinical Laboratory Techniques; Diffusion; Erythromycin; Guidelines as Topic; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2002 |
Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Resistance, Bacterial; Erythromycin; Europe, Eastern; Genes, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Streptococcus pyogenes | 2002 |
Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Ribosomes; Staphylococcus; Streptococcus | 2002 |
Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clindamycin; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Ketolides; Macrolides; Methyltransferases; Mutation; Staphylococcus aureus; Virginiamycin | 2002 |
In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Haemophilus influenzae; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus | 2002 |
The ketolide antibiotic ABT-773 is a specific inhibitor of translation and 50S ribosomal subunit formation in Streptococcus pneumoniae cells.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; In Vitro Techniques; Ketolides; Macrolides; Pneumococcal Infections; Protein Biosynthesis; Ribosomes; Staphylococcus aureus; Streptococcus pneumoniae | 2002 |
Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Erythromycin; Female; Genes, Bacterial; Genotype; Humans; Ketolides; Macrolides; Male; Microbial Sensitivity Tests; Pneumococcal Infections; Quebec; Streptococcus pneumoniae | 2002 |
Ketolides: the future of the macrolides?
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides; Methyltransferases; Ribosomes | 2002 |
Molecular analysis of constitutively expressed erm(C) genes selected in vitro by incubation in the presence of the noninducers quinupristin, telithromycin, or ABT-773.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; In Vitro Techniques; Ketolides; Macrolides; Microbial Sensitivity Tests; Mutation; Protein Biosynthesis; Selection, Genetic; Staphylococcus aureus; Virginiamycin | 2002 |
Comparison of telithromycin, a new ketolide, with erythromycin and clarithromycin for the treatment of Haemophilus influenzae pneumonia in suckling, middle aged and senescent mice.
Topics: Aging; Animals; Animals, Suckling; Anti-Bacterial Agents; Area Under Curve; Clarithromycin; Drug Administration Schedule; Drug Evaluation, Preclinical; Erythromycin; Haemophilus influenzae; Ketolides; Lung; Macrolides; Mice; Pneumonia, Bacterial; Tissue Distribution | 2002 |
Preferential inhibition of protein synthesis by ketolide antibiotics in Haemophilus influenzae cells.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Erythromycin; Haemophilus influenzae; Humans; Inhibitory Concentration 50; Ketolides; Macrolides; Microbial Sensitivity Tests; Protein Synthesis Inhibitors; Ribosomes | 2003 |
Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae.
Topics: Anti-Bacterial Agents; Clindamycin; Cross Infection; Drug Resistance, Bacterial; Erythromycin; Humans; Infant, Newborn; Ketolides; Macrolides; Microbial Sensitivity Tests; Spain; Streptococcal Infections; Streptococcus agalactiae; Tetracycline Resistance | 2003 |
Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Canada; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Gram-Negative Bacterial Infections; Haemophilus influenzae; Humans; Influenza, Human; Ketolides; Longitudinal Studies; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Moraxella catarrhalis; Respiratory Tract Infections; Tigecycline | 2003 |
Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
Topics: Anti-Bacterial Agents; Drug Resistance; Erythromycin; Genes, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Spain; Streptococcal Infections; Streptococcus pyogenes | 2003 |
Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactam Resistance; Ciprofloxacin; Erythromycin; Genotype; Humans; Incidence; Ketolides; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Prevalence; Streptococcus pneumoniae; Taiwan | 2003 |
Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Phenotype; Streptococcal Infections; Streptococcus pyogenes; Taiwan; Virginiamycin | 2003 |
Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefpodoxime; Ceftizoxime; Ceftriaxone; Child; Drug Resistance, Bacterial; Erythromycin; France; Humans; In Vitro Techniques; Josamycin; Ketolides; Macrolides; Penicillin G; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae | 2003 |
Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Ontario; Pharynx; Prevalence; Streptococcal Infections; Streptococcus pyogenes | 2003 |
Structural insight into the antibiotic action of telithromycin against resistant mutants.
Topics: Anti-Bacterial Agents; Binding Sites; Crystallization; Crystallography, X-Ray; Deinococcus; Drug Resistance, Bacterial; Erythromycin; Humans; Ketolides; Macrolides; Models, Molecular; Molecular Sequence Data; RNA, Ribosomal, 23S | 2003 |
Selection of ketolide resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; In Vitro Techniques; Ketolides; Macrolides; Mutation; Selection, Genetic; Staphylococcal Infections; Staphylococcus aureus | 2003 |
High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Clarithromycin; DNA Primers; Drug Resistance, Bacterial; Erythromycin; Ketolides; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Ribosomes; Streptococcus pneumoniae | 2003 |
In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities.
Topics: Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Erythromycin; Greece; Ketolides; Macrolides; Streptococcus pneumoniae; Streptococcus pyogenes | 2003 |
Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 Gram-positive cocci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clindamycin; Colony Count, Microbial; Drug Resistance, Bacterial; Erythromycin; Gram-Positive Cocci; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2003 |
In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Topics: Anti-Bacterial Agents; Erythromycin; Fluoroquinolones; Haemophilus influenzae; Humans; In Vitro Techniques; Ketolides; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae | 2003 |
Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Borrelia burgdorferi; Erythromycin; Humans; Ketolides; Lyme Disease; Macrolides; Microbial Sensitivity Tests | 2004 |
Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; North America; Pneumococcal Infections; Reverse Transcriptase Polymerase Chain Reaction; Streptococcus pneumoniae | 2004 |
Telithromycin susceptibility and genomic diversity of macrolide-resistant serotype III group B streptococci isolated in perinatal infections.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Erythromycin; Female; Genes, Bacterial; Humans; Infant, Newborn; Ketolides; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; Streptococcal Infections; Streptococcus agalactiae | 2004 |
Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacterial Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Quinolones | 2004 |
Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genes.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance; Erythromycin; Genes, Bacterial; Humans; Ketolides; Lincosamides; Linezolid; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcaceae; Streptogramin B; Tetracycline Resistance; Virginiamycin; Viridans Streptococci | 2004 |
High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Genotype; Germany; Ketolides; Macrolides; Membrane Proteins; Methyltransferases; Pneumococcal Infections; Reverse Transcriptase Polymerase Chain Reaction; Streptococcus pneumoniae | 2004 |
The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli.
Topics: Anti-Bacterial Agents; Arginine; Bacterial Outer Membrane Proteins; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enterobacter aerogenes; Erythromycin; Escherichia coli; Escherichia coli Proteins; Ketolides; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests | 2004 |
An examination of the differential sensitivity to ketolide antibiotics in ermB strains of Streptococcus pyogenes and Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Erythromycin; Ketolides; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Streptococcus pneumoniae; Streptococcus pyogenes | 2004 |
Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA.
Topics: Anti-Bacterial Agents; Erythromycin; Escherichia coli; Ketolides; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Plasmids; RNA, Ribosomal, 23S; Tylosin | 2004 |
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Ketolides; Macrolides; Microbial Sensitivity Tests; Mutation; Streptococcus pneumoniae; Time Factors | 2004 |
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Ketolides; Macrolides; Microbial Sensitivity Tests; Ribosomal Proteins; RNA, Ribosomal, 23S; Time Factors | 2004 |
Activity of telithromycin against erythromycin-susceptible and -resistant Streptococcus pneumoniae isolates from adults with invasive infections.
Topics: Adult; Drug Resistance, Bacterial; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae | 2004 |
Binding site of the bridged macrolides in the Escherichia coli ribosome.
Topics: Anti-Bacterial Agents; Base Sequence; Binding Sites; Binding, Competitive; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Ketolides; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Ribosomes; RNA, Ribosomal, 23S | 2005 |
In vitro activities of novel 2-fluoro-naphthyridine-containing ketolides.
Topics: Anti-Bacterial Agents; Bacteria; Colony Count, Microbial; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Naphthyridines; Respiratory Tract Infections; Staphylococcus; Streptococcus pneumoniae | 2005 |
Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Belgium; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; Ketolides; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Mutation; RNA, Ribosomal, 23S; Streptococcus pneumoniae | 2005 |
Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Binding Sites; Clindamycin; Crystallography; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Haloarcula marismortui; Ketolides; Mutation; Protein Binding; Ribosomes; RNA, Ribosomal, 23S; Virginiamycin | 2005 |
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Dogs; Epithelial Cells; Erythromycin; Humans; Ketolides; Macrolides; Mice; Neutrophils; Phagocytes | 2005 |
Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Humans; Infant, Newborn; Ketolides; Lincosamides; Macrolides; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications, Infectious; Spain; Streptococcal Infections; Streptococcus agalactiae | 2005 |
Induction of telithromycin resistance by erythromycin in isolates of macrolide-resistant Staphylococcus spp.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Coagulase; Drug Resistance, Multiple, Bacterial; Erythromycin; Gene Expression Regulation, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus | 2005 |
Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Erythromycin; Germany; Humans; Ketolides; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2005 |
Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations.
Topics: Anti-Bacterial Agents; Campylobacter; Clarithromycin; Dipeptides; DNA, Ribosomal; Drug Resistance, Multiple, Bacterial; Erythromycin; Ketolides; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation | 2005 |
Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and In Vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Genotype; Ketolides; Korea; Microbial Sensitivity Tests; Phenotype; Streptococcus pneumoniae | 2005 |
Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides.
Topics: Azithromycin; Bacterial Proteins; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gene Dosage; Humans; Ketolides; Macrolides; Membrane Proteins; Phenotype; Promoter Regions, Genetic; Streptococcus pneumoniae | 2005 |
Synthesis and antibacterial activity of 3-O-acyl-6-O-carbamoyl erythromycin A derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Erythromycin; Ketolides; Microbial Sensitivity Tests; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship | 2006 |
Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis.
Topics: Acute Disease; Child; Child, Preschool; Drug Resistance, Bacterial; Erythromycin; Genotype; Greece; Humans; Ketolides; Pharyngitis; Phenotype; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 2006 |
Sampling the antibiotic resistome.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Ketolides; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Rifampin; Soil Microbiology; Streptomyces; Trimethoprim Resistance; Vancomycin Resistance; Virginiamycin | 2006 |
Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects.
Topics: Anti-Bacterial Agents; Campylobacter; Doxycycline; Erythromycin; Finland; Fluoroquinolones; Humans; Ketolides; Microbial Sensitivity Tests | 2006 |
Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Aza Compounds; Cell Line; Dose-Response Relationship, Drug; Erythromycin; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Guinea Pigs; Heart Rate; Humans; Ketolides; Moxifloxacin; Quinolines; Risk Factors; Torsades de Pointes | 2006 |
Synthesis and antibacterial activity of novel C12 ethyl ketolides.
Topics: Animals; Anti-Bacterial Agents; Erythromycin; Ketolides; Methylation; Mice; Microbial Sensitivity Tests; Respiratory Tract Infections; Ribosomes; Streptococcus pneumoniae; Structure-Activity Relationship | 2006 |
Resistance phenotypes conferred by macrolide phosphotransferases.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Ketolides; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Plasmids; Recombination, Genetic | 2007 |
Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Italy; Ketolides; Macrolides; Microbial Sensitivity Tests; Pneumococcal Infections; Reverse Transcriptase Polymerase Chain Reaction; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2007 |
Activities of clindamycin, synercid, telithromycin, linezolid, and mupirocin against Gram-positive coccal strains resistant to erythromycin in Korea.
Topics: Acetamides; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Ketolides; Korea; Linezolid; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Virginiamycin | 2007 |
In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes.
Topics: Anti-Bacterial Agents; Clindamycin; Coagulase; Drug Resistance, Bacterial; Erythromycin; Ketolides; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptogramin A; Streptogramin B; Virginiamycin | 2007 |
The intracellular accumulation of phagocytic and epithelial cells and the inhibitory effect on Chlamydophila (Chlamydia) pneumoniae of telithromycin and comparator antimicrobials.
Topics: Anti-Bacterial Agents; Cell Line; Chlamydophila pneumoniae; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Epithelial Cells; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Minocycline; Phagocytes | 2008 |
In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Child; Drug Resistance, Bacterial; Erythromycin; Humans; Italy; Ketolides; Microbial Sensitivity Tests; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2008 |
Synthesis of novel macrolide derivatives with imidazo[4,5-b]pyridinyl sulfur contained alkyl side chains and their antibacterial activity.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Drug Design; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Imidazoles; Ketolides; Macrolides; Microbial Sensitivity Tests; Models, Chemical; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Sulfides; Sulfur | 2009 |
CEM-101 activity against Gram-positive organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Blotting, Southern; Clindamycin; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Egypt; Erythromycin; Gene Dosage; Humans; Ketolides; Macrolides; Polymerase Chain Reaction; Propionibacteriaceae; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid; Skin Diseases, Bacterial; Transcriptional Activation | 2010 |
Disposition of oral telithromycin in foals and in vitro activity of the drug against macrolide-susceptible and macrolide-resistant Rhodococcus equi isolates.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Azithromycin; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Bacterial; Epithelium; Erythromycin; Female; Horses; Ketolides; Linear Models; Lung; Macrolides; Male; Microbial Sensitivity Tests; Rhodococcus equi | 2010 |
Neuropsychological effects of macrolides.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Ketolides; Macrolides; Mental Disorders | 2010 |
Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action.
Topics: Anti-Bacterial Agents; Base Sequence; Chloramphenicol; Clindamycin; Deinococcus; Erythromycin; Escherichia coli; Haloarcula marismortui; Ketolides; Molecular Sequence Data; Molecular Structure; Peptidyl Transferases; Ribosomes; RNA, Ribosomal, 23S; X-Ray Diffraction | 2010 |
Revisiting the structures of several antibiotics bound to the bacterial ribosome.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Binding Sites; Chloramphenicol; Deinococcus; Erythromycin; Haloarcula marismortui; Ketolides; Molecular Structure; Ribosomes; Thermus thermophilus | 2010 |
Phylogenetic sequence variations in bacterial rRNA affect species-specific susceptibility to drugs targeting protein synthesis.
Topics: Aminoglycosides; Binding Sites; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Mycobacterium smegmatis; Phylogeny; RNA, Ribosomal; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S | 2011 |
Investigating the barriers to bioavailability of macrolide antibiotics in the rat.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Clarithromycin; Erythromycin; Hepatocytes; Ketolides; Macrolides; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Roxithromycin | 2012 |
Insights into the mode of action of novel fluoroketolides, potent inhibitors of bacterial protein synthesis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Erythromycin; Escherichia coli; Ketolides; Microbial Sensitivity Tests; Protein Biosynthesis; Ribosomes; RNA, Ribosomal, 23S | 2014 |
Parametrization of macrolide antibiotics using the force field toolkit.
Topics: Algorithms; Amino Sugars; Anti-Bacterial Agents; Azithromycin; Binding Sites; Erythromycin; Escherichia coli; Hexoses; Ketolides; Macrolides; Molecular Dynamics Simulation; Ribosomes; Static Electricity; Thermodynamics; Thermus thermophilus; Water | 2015 |
Nascent peptide assists the ribosome in recognizing chemically distinct small molecules.
Topics: Amino Acids; Anti-Bacterial Agents; Erythromycin; Gene Expression Regulation; Hexoses; Ketolides; Methyltransferases; Peptides; Protein Biosynthesis; Ribosomes; Substrate Specificity; Transcriptional Activation | 2016 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Toward the rational design of macrolide antibiotics to combat resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Design; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Escherichia coli Infections; Humans; Ketolides; Macrolides; Molecular Dynamics Simulation; Point Mutation; Ribosomes | 2017 |
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: relationship with macrolide resistance and clonal lineages.
Topics: A549 Cells; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Adhesion; Bacterial Proteins; Biofilms; Clindamycin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Female; Genotype; Humans; Ketolides; Macrolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multilocus Sequence Typing; Penicillin-Binding Proteins; Phenotype; Staphylococcal Infections; Staphylococcus aureus; Young Adult | 2019 |
Cytotoxic comparison of macrolide antibiotics and their chlorinated disinfection byproduct mixtures.
Topics: Anti-Bacterial Agents; Disinfectants; Disinfection; Drinking Water; Erythromycin; Halogenation; Ketolides; Toxicity Tests; Water Pollutants, Chemical; Water Purification | 2019 |
Solithromycin Can Specifically Induce Macrolide-Lincosamide-Streptogramin B Resistance.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacterial Proteins; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Gene Expression Regulation, Bacterial; Genes, Reporter; Genetic Engineering; Ketolides; Lac Operon; Lincosamides; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Miocamycin; Staphylococcus aureus; Streptogramin B; Transformation, Bacterial; Triazoles | 2020 |
Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics.
Topics: Amino Acid Motifs; Amino Acid Sequence; Anti-Bacterial Agents; Bacillus subtilis; Binding Sites; Cryoelectron Microscopy; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; Ketolides; Macrolides; Methyltransferases; Molecular Dynamics Simulation; Mutagenesis, Insertional; Protein Biosynthesis; Protein Synthesis Inhibitors; Ribosomes | 2021 |
The antimicrobial activity of cethromycin against Staphylococcus aureus and compared with erythromycin and telithromycin.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Ketolides; Lincosamides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Staphylococcal Infections; Staphylococcus aureus; Streptogramin B | 2023 |